—#66575

Product

Access Ultrasensitive Insulin Assay Kit, Part Number 33410. The product is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of insulin levels in human serum and plasma (EDTA) using the Access Immunoassay Systems. Beckman Coulter, Inc., Chaska, MN 55318.

FDA product code: CFP — Radioimmunoassay, Immunoreactive Insulin
Device class: Class 1
Medical specialty: Clinical Chemistry
510(k) numbers: K953084
Affected lot / code info: Part Number 33410, Lot Numbers: 714362 (Exp dt. 3/31/09), 716129 (Exp dt. 6/30/09), 718258 (Exp dt. 7/31/09), 519096 (Exp dt. 10/31/07), 521487 (Exp dt. 2/28/08), 616274 (Exp dt. 7/31/08), 617890 (Exp dt. 7/31/08), 617891 (Exp dt. 7/31/08) and 620204 (Exp dt. 12/31/08)

Why it was recalled

False negative results when used to test serum samples (as compared to plasma samples).

Root cause (FDA determination)

Other

Action the firm took

On September 19, 2007, Beckman Coulter mailed to its consignees an Urgent Product Corrective Action Letter informing them that the affected lots of the product were giving false negative results when used to test serum samples (as compared to plasma samples). The letter instructed consignees to discontinue using the affected lots of the product, and to re-test using an EDTA plasma sample if there was any discordance between the results of the serum sample (if it was obtained using an affected lot of the product) as compared with the clinical presentaion of the patient and the results of other diagnostic tests. The letter also instructed consignees to return, within 10 days, the Response Sheet .

Recalling firm

Firm: Beckman Coulter Inc
Address: 200 S Kraemer Blvd, Brea, California 92822-6208

Distribution

Distribution pattern: Worldwide: including USA and Canada.

Timeline

Recall initiated: 2007-09-19
Posted by FDA: 2008-06-25
Terminated: 2012-05-09
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #66575. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.